Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Jan;67(1):1–4.

Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

J Taverne, J Tavernier, W Fiers, J H Playfair
PMCID: PMC1542568  PMID: 3621669

Abstract

As tumour necrosis serum kills malarial parasites in vitro and inhibits the multiplication of some species of Plasmodium in mice, we examined the effect of recombinant mouse tumour necrosis factor (rTNF) on P. yoelii both in vitro and in vivo. Parasites incubated overnight with rTNF showed no loss of viability, but repeated injection of rTNF into infected mice reduced parasitaemia and significantly prolonged survival of mice infected with a lethal variant of the parasite. We conclude that TNF acts on blood-stage malaria in vivo via a host cell and that another molecule in tumour necrosis serum is involved in killing the parasite in vitro.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986 Apr 17;320(6063):584–588. doi: 10.1038/320584a0. [DOI] [PubMed] [Google Scholar]
  2. Carlin J. M., Jensen J. B., Geary T. G. Comparison of inducers of crisis forms in Plasmodium falciparum in vitro. Am J Trop Med Hyg. 1985 Jul;34(4):668–674. doi: 10.4269/ajtmh.1985.34.668. [DOI] [PubMed] [Google Scholar]
  3. Clark I. A., Virelizier J. L., Carswell E. A., Wood P. R. Possible importance of macrophage-derived mediators in acute malaria. Infect Immun. 1981 Jun;32(3):1058–1066. doi: 10.1128/iai.32.3.1058-1066.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fransen L., Müller R., Marmenout A., Tavernier J., Van der Heyden J., Kawashima E., Chollet A., Tizard R., Van Heuverswyn H., Van Vliet A. Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res. 1985 Jun 25;13(12):4417–4429. doi: 10.1093/nar/13.12.4417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Haidaris C. G., Haynes J. D., Meltzer M. S., Allison A. C. Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun. 1983 Oct;42(1):385–393. doi: 10.1128/iai.42.1.385-393.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Old L. J. Tumor necrosis factor (TNF). Science. 1985 Nov 8;230(4726):630–632. doi: 10.1126/science.2413547. [DOI] [PubMed] [Google Scholar]
  7. Playfair J. H., De Souza J. B., Freeman R. R., Holder A. A. Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Clin Exp Immunol. 1985 Oct;62(1):19–23. [PMC free article] [PubMed] [Google Scholar]
  8. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  9. Silberstein D. S., David J. R. Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1055–1059. doi: 10.1073/pnas.83.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stocker R., Hunt N. H., Clark I. A., Weidemann M. J. Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection. Infect Immun. 1984 Sep;45(3):708–712. doi: 10.1128/iai.45.3.708-712.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Taverne J., Depledge P., Playfair J. H. Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun. 1982 Sep;37(3):927–934. doi: 10.1128/iai.37.3.927-934.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Taverne J., Dockrell H. M., Playfair J. H. Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol. 1982 Mar;4(2):77–91. doi: 10.1111/j.1365-3024.1982.tb00421.x. [DOI] [PubMed] [Google Scholar]
  13. Taverne J., Matthews N., Depledge P., Playfair J. H. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol. 1984 Aug;57(2):293–300. [PMC free article] [PubMed] [Google Scholar]
  14. Thorne K. J., Richardson B. A., Taverne J., Williamson D. J., Vadas M. A., Butterworth A. E. A comparison of eosinophil-activating factor (EAF) with other monokines and lymphokines. Eur J Immunol. 1986 Sep;16(9):1143–1149. doi: 10.1002/eji.1830160919. [DOI] [PubMed] [Google Scholar]
  15. Wozencraft A. O., Dockrell H. M., Taverne J., Targett G. A., Playfair J. H. Killing of human malaria parasites by macrophage secretory products. Infect Immun. 1984 Feb;43(2):664–669. doi: 10.1128/iai.43.2.664-669.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES